MENU
ACOG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alpha Cognition (ACOG) Ownership - Who owns Alpha Cognition?
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease, for which there are limited or no treatment options... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
145.86M
P/E Ratio
N/A
Total Cash
45.53M
Projected Growth
N/A
Total Debt
2.21M
Revenue
2.93M
Risk (Beta)
3.03
Dividend Yield
N/A
Total Cash/Share
2.84
Total Debt/Equity
N/A
Revenue/Share
0.30 USD as % of share price
Fundamentals
ACOG
Capitalization
146M
P/E Ratio
N/A
Risk (Beta)
3.03
Dividend Yield
N/A
Total Cash
45.5M
Total Cash/Share
2.84
Total Debt
2.21M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.30%
Revenue
2.93M
ROE
N/A
Book Value
40.8M
P/B Ratio
3.57
Cash Flow
N/A
Earnings
-1.28
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
99.1M
Current Ratio
17.14
Current Revenue Per Employee
51379.89
Dividends Per Share - Security
N/A
EBITDA
-11.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
71.44
Revenue To Assets
-44.70
Shares Held By Institutions
33.1M
Shares Outstanding - Current
16M
Total Liabilities
7.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
54.584
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information